Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Cardiac Safety Services Market From 2025 To 2034?
The cardiac safety services market has experienced robust expansion recently. Its valuation is projected to increase from $1.06 billion in 2024 to $1.16 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.8%. This historical growth is attributable to factors such as advancements in drug development and clinical trials, stringent regulatory compliance needs, a rise in cardiovascular disorders, the worldwide expansion of clinical trials, and an emphasis on personalized medicine.
The cardiac safety services market is projected to experience swift expansion over the coming years. Its valuation is forecast to reach $1.75 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.7%. This anticipated growth during the forecast period stems from factors such as remote patient monitoring, a move towards decentralized clinical trials, the increase in orphan drug development, the growing practice of outsourcing clinical trials, and a regulatory focus on patient-centric methodologies. Key developments expected in the forecast period encompass the integration of wearable technologies, innovations in ECG technologies, the adoption of decentralized clinical trials, enhanced data standardization and interoperability, the expansion of telehealth and remote consultations, and the implementation of patient-centric approaches.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10137&type=smp
Which Factors And Drivers Are Influencing The Cardiac Safety Services Market In 2025?
The anticipated increase in cardiovascular disease prevalence is expected to drive the expansion of the cardiac safety services market. Cardiovascular diseases represent a category of disorders affecting the heart and blood vessels, such as peripheral arterial disease, cerebrovascular disease, and coronary heart disease. Cardiac safety services are dedicated to monitoring heart health and safety, identifying factors that contribute to cardiovascular disease before its onset, thereby enabling preventive measures and lowering mortality chances. For example, in March 2023, a journal from Oxford University Press reported that more than 200 million people were affected by peripheral artery diseases in 2020, a number projected to rise by nearly 50% by 2045. Furthermore, data published by the British Heart Foundation in September 2024 revealed that in the UK, approximately 7.6 million individuals are living with heart and circulatory diseases, including around 4 million males and 3.6 million females. These illnesses are responsible for about 27% of all deaths in the UK, amounting to over 170,000 deaths annually, which is roughly 480 deaths each day, or one death every three minutes. Thus, the growing prevalence of cardiovascular diseases is a key factor propelling the cardiac safety services market forward.
What Are The Major Segments Identified In The Cardiac Safety Services Market?
The cardiac safety servicesmarket covered in this report is segmented –
1) By Services: ECG Or Holter Measurements; Blood Pressure Measurements; In Vitro Cardiac Safety Assessment Services; Cardiovascular Imaging; Real-Time Telemetry Monitoring; Central Over-Read Of ECGS; Non-Invasive Cardiac Imaging; Physiologic Stress Testing; Thorough QT Studies; Other services
2) By Phase: Phase 1; Phase 2; Phase 3
3) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Research Organizations; Academic and Research Institute
Subsegments:
1) By ECG Or Holter Measurements: Standard ECG Monitoring; 24-Hour Holter Monitoring; Event Monitoring
2) By Blood Pressure Measurements: Continuous Blood Pressure Monitoring; Ambulatory Blood Pressure Monitoring; In-Hospital Blood Pressure Measurements
3) By In Vitro Cardiac Safety Assessment Services: Cardiomyocyte Toxicity Testing; Cardiac Ion Channel Testing; Mechanistic Studies
4) By Cardiovascular Imaging: Echocardiography; MRI Imaging; CT Angiography
5) By Real-Time Telemetry Monitoring: Remote Patient Monitoring; Continuous Telemetry Services
6) By Central Over-Read Of ECGs: ECG Interpretation Services; Quality Control And Reporting
7) By Non-Invasive Cardiac Imaging: Stress Testing; Nuclear Cardiology
8) By Physiologic Stress Testing: Exercise Stress Testing; Pharmacologic Stress Testing
9) By Thorough QT Studies: Clinical Trial Services; Safety Assessments For Drug Development
10) By Other Services: Cardiac Device Monitoring; Clinical Consultation Services
What Are The Major Trends Driving The Growth Of The Cardiac Safety Services Market?
Product innovations represent a key trend gaining traction in the cardiac safety services market. Major companies operating in the cardiac safety services market are concentrating their efforts on developing new solutions to fortify their market position. For example, in March 2022, CATHI, a Germany-based technology-driven company specializing in endovascular simulation technologies, unveiled CATHIS RHC 2, which is a new generation of Right Heart Catheter (RHC) simulators. CATHIS RHC 2 serves as an improved iteration, integrating all features of CATHI’s original RHC simulator, along with additional advantages like wire-assisted navigation and the potential for operation with real liquids (S-HUB), thereby facilitating thermodilution.
Who Are The Key Multinational Companies Dominating The Cardiac Safety Services Market?
Major companies operating in the cardiac safety services market include Laboratory Corporation of America Holdings, Banook Group Limited, Pharmaceutical Product Development LLC, Biotrial S.A., Certara Inc., Celerion Inc., Medpace Holdings Inc., Ncardia AG, Richmond Pharmacology Limited, PhysioStim, SGS Société Générale de Surveillance SA, Koninklijke Philips N.V., Clario, NEXEL Co. Ltd., Eurofins Scientific SE, InBody USA Inc., Spaulding Clinical Research LLC, OMRON Healthcare Inc., ERT Inc., IQVIA Holdings Inc., Bioclinica Inc., ICON plc, BioTelemetry Inc., Medidata Solutions Inc., SYNEXUS Clinical Research, PPD Inc., Parexel International Corporation, Chiltern International Limited, ACI Clinical Inc., Biomedical Systems, High Point Clinical Trials Center, Maastricht University Medical Centre+, CCBR-SYNARC, Cytel Inc., CardioSecur Ltd., Medicalgorithmics S.A., Advarra Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/cardiac-safety-services-global-market-report
Which Region Is Expected To Witness The Fastest Growth In The Cardiac Safety Services Market?
North America was the largest region in the cardiac safety services market in 2024. The regions covered in the cardiac safety services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Cardiac Safety Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=10137&type=smp
Browse Through More Reports Similar to the Global Cardiac Safety Services Market 2025, By The Business Research Company
Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report
Cardiac Assist Devices And Equipment Global Market Report 2025
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model








